March 2026: The TGA approved the importation of an alternative to ifosfamide 1 g and 2 g products currently in shortage under S19A of the Therapeutic Goods Act, 1989 until 31 July 2026  (unless lapsed on an earlier date). Contact Us for more details.

​

January 2026: The TGA approved the importation of an alternative to Pramipexole Dihydrochloride Tablets 0.125mg, Pramipexole Dihydrochloride Tablets 0.25mg, Pramipexole Dihydrochloride Tablets 1mg  products currently in shortage under S19A of the Therapeutic Goods Act, 1989 until 30 April 2026 for 1 mg and 30 May 2026 for 0.125 mg and 0.250 mg tablets (unless lapsed on an earlier date). Contact Us for more details.

​

January 2026: The TGA approved the importation of an alternative to teriparatide 0.25 mg/mL (250mcg/mL) solution for injection products currently in shortage under S19A of the Therapeutic Goods Act, 1989 until 30 April 2026 (unless lapsed on an earlier date). Contact Us for more details.

​

January 2026: The TGA approved the importation of an alternative to Topotecan injection 4mg/4mL intravenous infusion products currently in shortage under S19A of the Therapeutic Goods Act, 1989 until 31 March 2026 (unless lapsed on an earlier date). Contact Us for more details.

​​​​

Australian innovator in complex generic medicines

​​